Sonodynamic therapy doubled the median overall survival to 15.7 months and tripled progression-free survival to 5.5 months in ...

BIRMINGHAM, AL, USA I 4, 2024 I Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in ...

Benjamin Franklin once famously said that nothing in this world was certain except death and taxes. It is the one ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and manufacturing, today announced a strategic ...

The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...

The global breast cancer diagnostics market was valued at US$4.3b in 2022 and is expected to reach US$7.7b by 2030. Shares in ...

HMC Capital has announced the acquisition of Neoen’s Victorian renewable energy portfolio for $950m, marking a step in its ...